PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

International Journal of Cancer. Journal International Du Cancer
L RozendaalC J Meijer

Abstract

Cervical-cancer screening programmes using cytomorphological criteria could be more efficient if the screening included objective individual risk factors for women with normal cytology, such as a test for high-risk human papillomavirus (HPV). The value of a PCR-based test for high-risk HPV types was studied in a cohort of 1622 women presenting in a routine triannual population-based screening programme. Women were included in the study when they had no previous history of cervical dysplasia; and their initial Pap smear was read as normal (Pap 1 or 2). The mean age of the women was 42 years (range 34-54 years) and mean follow-up time was 40 months (range 5-73 months). Women were referred for colposcopically directed biopsies if they had had 2 successive cervical smears read as Pap 3a (mild to moderate dyskaryosis) or one read as > or = Pap 3b (severe dyskaryosis). Women with histologically confirmed cervical intraepithelial neoplasia grade III (CIN III) were considered positive cases. All women were tested for 14 high-risk HPV genotypes. Of the 86 high-risk HPV-positive women, 6 developed CIN III, whereas only 1 of the 1536 HPV-negative women did. The women with normal Pap smears containing high-risk HPV genotypes were 116 times...Continue Reading

References

Oct 1, 1992·The Journal of General Virology·M Van RanstR D Burk
Sep 1, 1991·British Journal of Cancer·G J van Oortmarssen, J D Habbema
Aug 1, 1974·American Journal of Obstetrics and Gynecology·L W Coppleson, B Brown
Jun 17, 1995·Lancet·J CuzickJ Guillebaud
Apr 18, 1996·The New England Journal of Medicine·S A Cannistra, J M Niloff
Mar 15, 1996·International Journal of Cancer. Journal International Du Cancer·D JenkinsS Gallivan
Nov 15, 1995·Cancer·M H Schiffman, L A Brinton

❮ Previous
Next ❯

Citations

Mar 22, 2002·The Lancet Oncology·A Ferenczy, E Franco
Feb 5, 1999·BMJ : British Medical Journal·C Sherlaw-JohnsonD Jenkins
Aug 17, 1999·Sexually Transmitted Infections·H B LaceyP M Green
Apr 18, 2000·Journal of Clinical Pathology·C J Meijer, J M Walboomers
Aug 10, 2001·Infectious Diseases in Obstetrics and Gynecology·R R FinanW Y Almawi
Mar 29, 2002·Journal of Clinical Pathology·F X BoschK V Shah
Jan 13, 2004·Journal of Clinical Microbiology·Hsing-Pei LinJau-Tsuen Kao
Jul 10, 2004·Journal of Clinical Microbiology·K SotlarB Bültmann
Oct 18, 2006·BMC Public Health·Ahti AnttilaPekka Nieminen
Oct 31, 2007·Population Health Metrics·Jeremy D Goldhaber-FiebertJoshua A Salomon
Feb 17, 2010·BMC Infectious Diseases·Petroula StamatakiGeorge Saroglou
Nov 26, 1999·The New England Journal of Medicine·K L WallinJ Dillner
Oct 7, 2011·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·E S ÖzcanF Ortaç
Mar 15, 2005·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·J BhaumikA E Davies
Dec 10, 1998·The American Journal of Pathology·C P Crum
Feb 5, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·C J L M MeijerP J F Snijders
Jul 2, 2009·Vaccine·Veerle M H CoupéJohannes Berkhof
Oct 16, 2013·Journal of Medical Virology·Jira ChansaenrojYong Poovorawan
Oct 1, 2008·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Jennifer S SmithJeanne M Pimenta
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Johannes BerkhofChris J L M Meijer
Aug 15, 2003·International Journal of Cancer. Journal International Du Cancer·Sue J GoldieEduardo Franco
Jul 25, 2009·Journal of Medical Virology·Christine C RobertsJanine T Bryan
Sep 2, 2003·The Journal of Pathology·Peter J F SnijdersChris J L M Meijer
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Matti LehtinenPentti Koskela
Nov 28, 2008·International Journal of Cancer. Journal International Du Cancer·Veerle M H CoupéJohannes Berkhof
Dec 31, 2010·International Journal of Cancer. Journal International Du Cancer·Tiina PetäjäDominique Descamps
Mar 23, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Chris PerronsNicola Brink
Apr 28, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V DalsteinC Mougin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.